Search research articles
Contact Us
Filters
Showing results (231-240 of 631) with videos related to
Page
of 64
Sort By:
Plos One
|
November 14, 2014
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
Simone Susser, Eva Herrmann, Christian Lange, et al.
Familial Cancer
|
January 26, 2018
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis
Astrid Tenden Stormorken, Thomas Berg, Ole-Jacob Norum, et al.
Zeitschrift Fur Gastroenterologie
|
April 22, 2026
[Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)]
Bernd Heinrich, Peter Buggisch, Gerlinde Teuber, et al.
Analytical and Bioanalytical Chemistry
|
July 11, 2006
Coupling of imaging NEXAFS with secondary ion mass spectrometry for the chemical and isotopic analysis of presolar cosmic grains
Thomas Berg, Jochen Maul, Nicole Erdmann, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines
Christoph Schmöcker, Karsten H Weylandt, Lena Kahlke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 21, 2008
Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs
Olav A Gressner, Chunfang Gao, Katharina Rehbein, et al.
Journal of Clinical Immunology
|
May 21, 2009
Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response
Stephan L Haas, Christel Weiss, Peter Bugert, et al.
European Radiology
|
December 17, 2011
Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours
Federico Collettini, Dirk Schnapauff, Alexander Poellinger, et al.
Journal of Clinical and Experimental Hepatology
|
October 6, 2025
Exploring the Impact of Therapeutic Plasma Exchange on Organ Function in Patients With ACLF: A Retrospective, Single-center Propensity Score-matched Cohort Study
Jonas Schumacher, Reinhard Henschler, Raymund Buhmann, et al.
Alimentary Pharmacology & Therapeutics
|
December 4, 2024
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
Toni Herta, Anna Joachim-Richter, David Petroff, et al.
Page
of 64
Search research articles
Search
Showing results (231-240 of 631) with videos related to
Sort By:
Page
of 64
Plos One
|
November 14, 2014
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
Simone Susser, Eva Herrmann, Christian Lange, et al.
Familial Cancer
|
January 26, 2018
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis
Astrid Tenden Stormorken, Thomas Berg, Ole-Jacob Norum, et al.
Zeitschrift Fur Gastroenterologie
|
April 22, 2026
[Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)]
Bernd Heinrich, Peter Buggisch, Gerlinde Teuber, et al.
Analytical and Bioanalytical Chemistry
|
July 11, 2006
Coupling of imaging NEXAFS with secondary ion mass spectrometry for the chemical and isotopic analysis of presolar cosmic grains
Thomas Berg, Jochen Maul, Nicole Erdmann, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2007
Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines
Christoph Schmöcker, Karsten H Weylandt, Lena Kahlke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 21, 2008
Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs
Olav A Gressner, Chunfang Gao, Katharina Rehbein, et al.
Journal of Clinical Immunology
|
May 21, 2009
Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response
Stephan L Haas, Christel Weiss, Peter Bugert, et al.
European Radiology
|
December 17, 2011
Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours
Federico Collettini, Dirk Schnapauff, Alexander Poellinger, et al.
Journal of Clinical and Experimental Hepatology
|
October 6, 2025
Exploring the Impact of Therapeutic Plasma Exchange on Organ Function in Patients With ACLF: A Retrospective, Single-center Propensity Score-matched Cohort Study
Jonas Schumacher, Reinhard Henschler, Raymund Buhmann, et al.
Alimentary Pharmacology & Therapeutics
|
December 4, 2024
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
Toni Herta, Anna Joachim-Richter, David Petroff, et al.
Page
of 64